These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 37979234)
1. Mimicking Clinical Rejection Patterns in a Rat Osteomyocutaneous Flap Model of Vascularized Composite Allotransplantation. Beare JE; Fleissig Y; Kelm NQ; Reed RM; LeBlanc AJ; Hoying JB; Kaufman CL J Surg Res; 2024 Mar; 295():28-40. PubMed ID: 37979234 [TBL] [Abstract][Full Text] [Related]
2. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation. Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238 [TBL] [Abstract][Full Text] [Related]
3. Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research. Fleissig Y; Reed RM; Beare JE; LeBlanc AJ; Williams SK; Kaufman CL; Hoying JB J Vis Exp; 2019 Apr; (146):. PubMed ID: 31081823 [TBL] [Abstract][Full Text] [Related]
4. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival. Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714 [TBL] [Abstract][Full Text] [Related]
5. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts. Arenas Hoyos I; Helmer A; Yerly A; Lese I; Hirsiger S; Zhang L; Casoni D; Garcia L; Petrucci M; Hammer SE; Duckova T; Banz Y; Montani M; Constantinescu M; Vögelin E; Bordon G; Aleandri S; Prost JC; Taddeo A; Luciani P; Rieben R; Sorvillo N; Olariu R Front Immunol; 2024; 15():1387945. PubMed ID: 38887281 [TBL] [Abstract][Full Text] [Related]
6. Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update. Kanitakis J; Petruzzo P; Badet L; Gazarian A; Thaunat O; Testelin S; Devauchelle B; Dubernard JM; Morelon E Transplantation; 2016 Oct; 100(10):2053-61. PubMed ID: 27163543 [TBL] [Abstract][Full Text] [Related]
7. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation. Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of rejection in vascular composite allotransplantation. Etra JW; Raimondi G; Brandacher G Curr Opin Organ Transplant; 2018 Feb; 23(1):28-33. PubMed ID: 29189293 [TBL] [Abstract][Full Text] [Related]
9. Sensitization and Desensitization in Vascularized Composite Allotransplantation. Moris D; Cendales LC Front Immunol; 2021; 12():682180. PubMed ID: 34456906 [TBL] [Abstract][Full Text] [Related]
10. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179 [TBL] [Abstract][Full Text] [Related]
11. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model. Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417 [TBL] [Abstract][Full Text] [Related]
12. Cellular activation pathways and interaction networks in vascularized composite allotransplantation. Knoedler L; Knoedler S; Panayi AC; Lee CAA; Sadigh S; Huelsboemer L; Stoegner VA; Schroeter A; Kern B; Mookerjee V; Lian CG; Tullius SG; Murphy GF; Pomahac B; Kauke-Navarro M Front Immunol; 2023; 14():1179355. PubMed ID: 37266446 [TBL] [Abstract][Full Text] [Related]
13. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats. Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086 [TBL] [Abstract][Full Text] [Related]
14. Adipose-derived stromal cell therapy combined with a short course nonmyeloablative conditioning promotes long-term graft tolerance in vascularized composite allotransplantation. Schweizer R; Taddeo A; Waldner M; Klein HJ; Fuchs N; Kamat P; Targosinski S; Barth AA; Drach MC; Gorantla VS; Cinelli P; Plock JA Am J Transplant; 2020 May; 20(5):1272-1284. PubMed ID: 31774619 [TBL] [Abstract][Full Text] [Related]